Prior to joining Resonant, Whisenhunt served as vice president of international sales at Xoft, Inc., as well as vice president of computed tomography at Phillips Medical. Prior to that, Whisenhunt held the position of vice president and general manager of oncology business at Picker Medical Systems and spent four years as the director of oncology marketing for GE Medical Systems. Stephen is a member of The New York Academy of Sciences and holds degrees from LaSalle University and Frederick Taylor University.
“Stephen’s experience in the radiation oncology market and proven track record of success will be a great asset to Resonant Medical as we continue to grow our United States customer base,” said Tony Falco, president and founder of Resonant. “Stephen will play a pivotal role in expanding our market presence, meeting the market’s demand for the Clarity System and managing our relationships with our distributors. We are pleased to welcome him to the executive team and look forward to seeing the benefits of his leadership and proven sales execution abilities.”
“Resonant’s technology provides a solution for a clearly unmet need in breast cancer treatment—addressing the issue of tumor movement for breast and prostate cancer patients in a way that has never been done before,” said Whisenhunt. “It is exciting to be part of a growing organization producing state-of-the-art technology to help so many patients in need. I look forward to using my knowledge and experience in this industry to help foster the growth of the company, bringing this technology to patients undergoing radiation therapy.”
